Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (HKG:6990)
Hong Kong · Delayed Price · Currency is HKD 506.00
-14.00 (-2.69%)
At close: Apr 20, 2026
HKG:6990 Market Cap
HKG:6990 has a market cap or net worth of 117.99 billion as of April 20, 2026. Its market cap has increased by 103.60% in one year.
Market Cap
117.99B
Enterprise Value
113.11B
Revenue
2.29B
Ranking
n/a
PE Ratio
n/a
Stock Price
506.00
Market Cap Chart
Since July 11, 2023, HKG:6990's market cap has increased from 13.49B to 117.99B, an increase of 774.71%. That is a compound annual growth rate of 118.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 117.99B | 29.02% |
| Dec 31, 2025 | 91.46B | 146.43% |
| Dec 31, 2024 | 37.11B | 64.54% |
| Dec 29, 2023 | 22.56B | 67.21% |
| Jul 11, 2023 | 13.49B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 281.22B |
| Innovent Biologics | 158.77B |
| WuXi Biologics | 147.80B |
| Akeso | 139.09B |
| Sino Biopharmaceutical | 107.21B |
| RemeGen | 85.82B |
| 3SBio | 63.09B |
| Shanghai Junshi Biosciences | 47.19B |